PT Bundamedik Tbk Statistics

Total Valuation

PT Bundamedik Tbk has a market cap or net worth of IDR 2.06 trillion. The enterprise value is 2.96 trillion.

Market Cap	2.06T
Enterprise Value	2.96T

Important Dates

The next estimated earnings date is Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

PT Bundamedik Tbk has 8.60 billion shares outstanding.

Current Share Class	n/a
Shares Outstanding	8.60B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	16.27%
Owned by Institutions (%)	n/a
Float	1.85B

Valuation Ratios

The trailing PE ratio is 158.22 and the forward PE ratio is 63.16.

PE Ratio	158.22
Forward PE	63.16
PS Ratio	1.34
PB Ratio	1.29
P/TBV Ratio	1.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.45, with an EV/FCF ratio of -13.26.

EV / Earnings	227.03
EV / Sales	1.92
EV / EBITDA	12.45
EV / EBIT	29.04
EV / FCF	-13.26

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.69.

Current Ratio	1.76
Quick Ratio	1.62
Debt / Equity	0.69
Debt / EBITDA	6.28
Debt / FCF	-6.69
Interest Coverage	1.74

Financial Efficiency

Return on equity (ROE) is 1.38% and return on invested capital (ROIC) is 1.95%.

Return on Equity (ROE)	1.38%
Return on Assets (ROA)	1.88%
Return on Capital (ROIC)	1.95%
Revenue Per Employee	1.08B
Profits Per Employee	9.10M
Employee Count	1,434
Asset Turnover	0.46
Inventory Turnover	17.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.40% in the last 52 weeks. The beta is -0.22, so PT Bundamedik Tbk's price volatility has been lower than the market average.

Beta (5Y)	-0.22
52-Week Price Change	-31.40%
50-Day Moving Average	272.20
200-Day Moving Average	296.54
Relative Strength Index (RSI)	39.92
Average Volume (20 Days)	2,515,560

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Bundamedik Tbk had revenue of IDR 1.55 trillion and earned 13.05 billion in profits. Earnings per share was 1.52.

Revenue	1.55T
Gross Profit	708.05B
Operating Income	102.03B
Pretax Income	54.62B
Net Income	13.05B
EBITDA	208.68B
EBIT	102.03B
Earnings Per Share (EPS)	1.52

Full Income Statement

Balance Sheet

The company has 1.16 trillion in cash and 1.49 trillion in debt, giving a net cash position of -337.50 billion or -39.23 per share.

Cash & Cash Equivalents	1.16T
Total Debt	1.49T
Net Cash	-337.50B
Net Cash Per Share	-39.23
Equity (Book Value)	2.16T
Book Value Per Share	185.62
Working Capital	618.19B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 61.33 billion and capital expenditures -284.70 billion, giving a free cash flow of -223.37 billion.

Operating Cash Flow	61.33B
Capital Expenditures	-284.70B
Free Cash Flow	-223.37B
FCF Per Share	-25.96

Full Cash Flow Statement

Margins

Gross margin is 45.79%, with operating and profit margins of 6.60% and 0.84%.

Gross Margin	45.79%
Operating Margin	6.60%
Pretax Margin	3.53%
Profit Margin	0.84%
EBITDA Margin	13.50%
EBIT Margin	6.60%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 0.63%.

Dividend Per Share	1.50
Dividend Yield	0.63%
Dividend Growth (YoY)	-62.67%
Years of Dividend Growth	n/a
Payout Ratio	36.92%
Buyback Yield	n/a
Shareholder Yield	0.63%
Earnings Yield	0.63%
FCF Yield	-10.82%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PT Bundamedik Tbk has an Altman Z-Score of 1.85. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.85
Piotroski F-Score	n/a